Biogen制药 | 201.18 +15.82 +8.53% | ||
| BIIB | |||
| 高 202.41 | 开 187.01 | 量 340.49万股 | 总市值 295.14亿 |
| 低 184.60 | 换 2.32% | 额 6.70亿 | 市盈TTM 22.83 |
分时
5日
日K
周K
月K
季K
年K
Biogen制药(BIIB)
昨天20:45
$Biogen制药(BIIB)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000875045-26-000013 Act: 34 Size: 26 MB 网页链接
Biogen制药(BIIB)
昨天20:05
$Biogen制药(BIIB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000875045-26-000011 Act: 34 Size: 780 KB 网页链接
Biogen制药(BIIB)
昨天02:25
$Biogen制药(BIIB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-26-000383 Act: 34 Size: 11 KB 网页链接
Biogen制药(BIIB)
02-04 06:25
$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000007 Size: 9 KB 网页链接
Biogen制药(BIIB)
02-03 00:15
$Biogen制药(BIIB)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-000517 Act: 33 Size: 4 KB 网页链接
Biogen制药(BIIB)
01-14 19:05
$Biogen制药(BIIB)$ 8-K Current report, item 2.02 Accession Number: 0000875045-26-000003 Act: 34 Size: 202 KB 网页链接
Biogen制药(BIIB)
2025-12-04 05:45
$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-25-000052 Size: 8 KB 网页链接
Biogen制药(BIIB)
2025-11-14 09:35
$Biogen制药(BIIB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000763212-25-000007 Act: 34 Size: 7 KB 网页链接
Biogen制药(BIIB)
2025-11-10 21:25
$Biogen制药(BIIB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000093751-25-000581 Act: 34 Size: 8 KB 网页链接
Biogen制药(BIIB)
2025-11-05 05:15
$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-25-000051 Size: 8 KB 网页链接
Biogen制药(BIIB)
2025-10-30 18:35
$Biogen制药(BIIB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000875045-25-000049 Act: 34 Size: 17 MB 网页链接
Biogen制药(BIIB)
2025-10-30 18:15
$Biogen制药(BIIB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000875045-25-000047 Act: 34 Size: 770 KB 网页链接
1讨论
Biogen制药(BIIB)
2025-10-15 04:25
$Biogen制药(BIIB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000875045-25-000040 Act: 34 Size: 205 KB 网页链接
Biogen制药(BIIB)
2025-10-07 01:05
$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-25-000037 Size: 8 KB 网页链接
Biogen制药(BIIB)
2025-09-03 06:05
$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-25-021083 Size: 9 KB 网页链接
Biogen制药(BIIB)
2025-09-03 00:55
$Biogen制药(BIIB)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-005676 Act: 33 Size: 4 KB 网页链接
Biogen制药(BIIB)
2025-07-31 18:15
$Biogen制药(BIIB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000875045-25-000033 Act: 34 Size: 16 MB 网页链接
Biogen制药(BIIB)
2025-07-31 18:15
$Biogen制药(BIIB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000875045-25-000035 Act: 34 Size: 739 KB 网页链接
Biogen制药(BIIB)
2025-07-31 06:05
$Biogen制药(BIIB)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950157-25-000596 Size: 7 KB 网页链接
Biogen制药(BIIB)
2025-07-22 09:25
$Biogen制药(BIIB)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950157-25-000586 Size: 9 KB 网页链接